Antibody has been postulated to regulate its production through a feedback mechanism, which modulates the amount of antigen available in immunogenic form (1). However, new antibody synthesis may occur even in the presence of a large excess of circulating antibody, e.g., after secondary immunization or after reduction of serum antibody levels by exchange transfusion or immunoadsorbants (2-4) . Since stimulation of B cells to antibody-secreting cells requires the interaction of antigen with specific cell surface binding sites, these findings suggest that immune cells are able to capture antigen even in the presence of a large excess of antibody .
Walter and Eliza Hall Institute, Melbourne, Australia), were carried by serial transplantation in female BALB/c mice . Single cell suspensions were prepared as previously described (5) .
Antigens . Dinitrophenylated bovine serum albumin (DNP-BSA)' and N-2,4-dinitrophenyl-Eamino-N-caproic acid (DNP-EACA) were prepared as previously described (5, 8) . There were approximately 23 DNP groups per molecule of DNP-BSA based upon its absorbancy at 360 nm when e=17,500 for DNP-lysine . DNP-BSA was radiolabeled by lactoperoxidase-catalyzed iodination (9) Research Div., Kankakee, Ill.) . Cells were washed with 2 ml of PBS three times for DNP-BSA-binding studies, and once for studies with DNP-EACA .
Cell-bound radioactivity was measured as previously described (5), and the amount of cell-bound DNP conjugate was calculated from its specific activity . Specific binding was calculated by subtracting from the amount of DNP conjugate bound to MOPC 315 cells that bound nonspecifically to control murine myeloma cells (HP-76) . Effect of Time of Incubation . Earlier studies have shown that specific binding of DNP conjugates to MOPC 315 cells increases with time of incubation (5). The effect of this variable on antigen binding to these cells in the presence of specific Ig was tested . 0.5 ml of [" 5 I]DNP-BSA (5 x 10 -12 mol) was preincubated with 0.5 ml of undiluted MOPC 315 or normal mouse serum for 30 min to mimic the in vivo situation where antigen most likely interacts with antibody before reacting with cells . 12 million MOPC 315 or control myeloma cells were added in 3 ml of PBS, and duplicate 0 .2-ml aliquots of the resulting suspension assayed at several time intervals thereafter . Under the conditions of this experiment, the ratio of free to cell surface binding sites was 10,000 to 1 . As can be seen in Table 1 , specific binding of [1211JDNP-BSA to MOPC 315 cells occurred within 30 s in the presence of normal mouse serum, and increased thereafter . MOPC 315 serum completely inhibited specific binding of the conjugate initially, but specific binding did occur after 30 min and increased slowly thereafter . Thus a prolonged period of time is required to establish equilibrium.
Results

Effect of Specific
Effect of Specific Ig on Binding of Univalent Conjugate to Cells . The effect of specific Ig on the binding of the univalent conjugate [3H ]DNP-EACA to MOPC 315 cells was determined as described above with [' 25 I]DNP-BSA, except that BSA was omitted and the cells were washed only once with PBS . Prior studies had indicated these modifications were necessary to obtain optimal specific binding of this ligand to MOPC 315 cells (5) . The result of a representative experiment is shown in Fig. 3 
Discussion
The main finding of this study is that immune cells can specifically bind and retain antigen in the presence of a large excess of specific Ig . This finding provides a partial explanation for the ability of a small amount of antigen to stimulate immunocytes in the presence of excess antibody as occurs in secondary immunization, in the persistent antibody response to slowly catabolized antigen (11), or after the partial depletion of circulating antibody (2-4) .
In the past we have suggested that antibody regulates its own synthesis through a feedback mechanism, the central feature of which is a dynamic equilibrium between circulating antibody and persisting immunogen (1) . In the presence of large amounts of antibody, which late in the immune response will be of high affinity, the quantity of available free immunogen will be very small . Cells must consequently have an advantage over antibody if they are to effectively interact with antigen. B-cell binding of antigen may be favored by a number of mechanisms including helper T cells, presentation of antigen on macrophage surface, and antigen concentration in specific anatomical areas of lymphoid organs (12) . In addition, cells having multiple binding sites and thus an effective valence probably much greater than that of circulating antibody, may be able to bind antigen more avidly than antibody . Theoretical considerations (13) and in vitro experiments (14) (15) (16) (17) (18) indicate that multiple bond formation causes a marked enhancement of binding energy . We have confirmed that these considerations apply to the binding of antigen by cells. By direct measurement, the binding affinity of polyvalent antigen to MOPC 315 cells is 100-300 times greater than that of univalent antigen of similar specificity (5) .
This study allows the competition between specific free Ig and immunocytes for specific antigen to be expressed quantitatively . Under the conditions of these experiments, approximately 90 binding sites on free Ig were required per cell surface binding site to inhibit by 50% specific binding of DNP-BSA. Significant specific binding still occurred with a 30,000-fold excess of free Ig per cell surface binding site or in the presence of 1 .25 x 10 9 molecules of Ig per MOPC 315 cell . On the basis of reasonable assumptions it is possible to extend these numbers to a biological framework and demonstrate that cells can effectively capture a small quantity of antigen administered to an animal with a high concentration of circulating antibody . If it is assumed that a mouse hyperimmunized to DNP-BSA has an IgG concentration of 20 mg/ml, that 10% of it is specific antibody, and that extravascular IgG concentration is 50% that of serum, then it can be calculated and there will be 3.1 x 10 15 molecules of IgG per ml of extravascular fluid. If this mouse is boosted with 0.1 mg of DNP-BSA and it is assumed that the antigen is distributed freely throughout all tissues (density assumed to be similar to water: 1 g/ml), then the concentration of the antigen in a 30 g mouse will be 3 .3 leg/ml . The concentration of DNP-BSA molecules, based on a mol wt of 84,000, would be 2.43 x 10 13/ml . The ratio of antibody to antigen molecules will be approximately 100 to 1 . This ratio will be lower if, as is probable, DNP-BSA does not enter intracellular spaces . In our experiments the concentration of DNP-BSA was 1 .7 x 10' 2 molecules per ml and that of MOPC 315 Ig at which specific antigen binding to cell still occurred 1 .4 x 10' 5 molecules per ml . The ratio of antibody to antigen was approximately 1,000 to 1. Thus, specific antigen binding to cells occurred in vitro at a lower concentration of antigen and in the presence of greater excess of antibody than that estimated to be present in vivo during secondary immunization .
Antigen tends to preferentially localize, and is thus concentrated, in specific anatomic areas of lymphoid organs, whereas extravascular antibody is in equilibrium with serum Ig and hence presumably at a similar concentration throughout the extravascular space . Consequently, the ratio of antibody to antigen at the actual site of antigen interaction with cells will probably be lower than that calculated above, shifting the reaction in favor of antigen binding to cells. The presence in MOPC 315 serum of antibody to myeloma-associated antigens or to idiotypic determinants on cell surface IgA would not alter these conclusions. Indeed, by binding to MOPC 315 cells such antibodies might reduce the effective number of available binding sites for DNP-BSA so that the actual ability of MOPC 315 cells to compete for antigen would be even greater than that observed in these experiments . Nor would the higher binding affinity of antibody formed late in the immune response in comparison to that of MOPC 315 alter these conclusions since it would be matched by a comparable increase in the binding affinity of cell surface binding sites (19) . In fact, a discrepancy between the binding affinity of serum antibody and that of binding sites on potential antibody-forming cells may explain the ability of passive antibody to suppress the primary antibody response at serum concentrations which do not inhibit the secondary response (21) . Antibody-mediated suppression is most efficient with high affinity antibody (20, 21) which will probably bind antigen more effectively than cells whose binding sites are of low average affinity at the onset of immunization .
Total and specific antigen binding to cell was time dependent. Prolonged incubation permitted specific antigen binding to cells in spite of concentrations of specific Ig which completely inhibited specific binding initially . Thus equilibrium between antigen, circulating antibody, and specific cells is achieved slowly in vitro, and perhaps not at all in complex and dynamic in vivo systems . The rate of reaching equilibrium may play a critical role in influencing the amount of antigen bound to cells. The effect of free antibody is probably to reduce the effective free antigen concentration and thus to slow the forward rate of the reaction of antigen with cell surface binding sites. It is probable that once antigen interacts with cell surface binding sites multiple bonds are readily formed as a consequence of the mobility of cell surface Ig, and the probability of the antigen-cell complex dissociating becomes very low. Thus, one would predict that if sufficient time were allowed, circulating antibody would actually be very inefficient in blocking binding of multivalent antigens to cells .
After prolonged incubation with anti-DNP Ig and DNP-BSA, MOPC 315 cells still bound considerably more of the conjugate than did control myeloma cells . Furthermore, the rate of increase in DNP-BSA binding was greater to MOPC 315 cells than to control cells. Since both MOPC 315 and control cell suspensions presumably contain a similar proportion of macrophages, these findings make it unlikely that cells coated with cytophillic antibody contribute to the greater binding of DNP-BSA to MOPC 315 as compared to control cells.
Binding of univalent DNP-EACA to cells was inhibited by specific Ig more readily than that of the multivalent conjugate. Strict comparisons cannot be made between these experiments, because they could not be performed under precisely comparable variables. Binding of DNP-BSA and DNP-EACA was studied at similar concentration of cells, antibody, and DNP groups, but the molar concentration of DNP-BSA was 23 times less than that of DNP-EACA (because there were 23 DNP groups per DNP-BSA molecules) . Furthermore, under the conditions of these assays, bound DNP-BSA occupied 30% of available binding sites on MOPC 315 cells, whereas DNP-EACA occupied only 7% of available sites. However, our earlier studies have shown that the binding of univalent hapten to cells is markedly weaker than that of multivalent ligands of similar specificity (5) . Binding of univalent hapten to cells was so weak, that 90% of it could be blocked by physiological concentrations of proteins . These findings suggest that the arrangement of antigenic determinants into a polyvalent array is necessary to achieve adequate binding of antigen to cells. Thus, the carrier requirement for immune response to hapten may be, in part, to present the hapten in the polyvalent form required for its binding to immunocytes.
These experiments and those of others (5, (22) (23) (24) indicate that antigen is capable of binding nonspecifically to a variety of cells, and that binding is augmented by aggregation of the antigen into immune complexes by antibody to the hapten or the carrier . Nonspecific enhancement of antigen binding to cells by small amounts of antibody may provide a helper mechanism that promotes immune responses at low antigen concentration by increasing antigen binding to lymphoid cells and to macrophages. This mechanism would operate in addition to the antigen-concentrating function provided by specific antigen-binding sites on B and T cells, and may be mediated by Ig and complement receptors on B cells and macrophages . This mechanism might be one of the factors contributing to the augmentation of antibody formation by low doses of passive antibody (25) (26) (27) and the increased antihapten antibody response resulting from preimmunization with carrier (28) (29) (30) . Finally increased cellular binding of antigen presented as immune complexes would be consistent with mediation of T-and B-cell cooperation by carrier-specific antibody, a possibility suggested by Bretscher and Cohn (31) and by Feldmann (32) .
Summary
The effect of specific immunoglobulin (Ig) on specific binding of antigen to cells has been studied in a model system consisting of murine myeloma cells (MOPC 315), MOPC 315 serum, and DNP conjugates . MOPC 315 serum, which has IgA specific for DNP, specifically inhibited the binding of DNP conjugates to these cells .
Using this model it was found that cells have a marked advantage over free specific Ig in binding multivalent antigen molecules and retaining them in a bound state . Cells were able to specifically bind multivalent antigen in the presence of a large excess of free specific Ig . The kinetics of antigen binding to cells was slow, and prolongation of time of incubation increased the amount of specific binding . Both antihapten and anticarrier Ig augmented nonspecific binding of multivalent but not of univalent hapten to control cells . Furthermore, antihapten Ig at low concentration increased antigen binding to specific cells .
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